About Changhua Christian Hospital; Hematology-Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Changhua Christian Hospital; Hematology-Oncology
During the past decade, Changhua Christian Hospital; Hematology-Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2015-03-31
2020-12-07
Completed
1,202
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]
2015-06-11
2021-02-17
Completed
1,021
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Changhua Christian Hospital; Hematology-Oncology"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Changhua Christian Hospital; Hematology-Oncology
According to Clinical.Site data, the most researched conditions in "Changhua Christian Hospital; Hematology-Oncology" are
"Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Changhua Christian Hospital; Hematology-Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Changhua Christian Hospital; Hematology-Oncology
Most popular intervention types in "Changhua Christian Hospital; Hematology-Oncology" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Changhua Christian Hospital; Hematology-Oncology
The vast majority of trials in "Changhua Christian Hospital; Hematology-Oncology" are
3 trials for "All" genders.
Clinical Trials Status at Changhua Christian Hospital; Hematology-Oncology
Currently, there are NaN active trials in "Changhua Christian Hospital; Hematology-Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Changhua Christian Hospital; Hematology-Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Changhua Christian Hospital; Hematology-Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".